Skip to main content

Advertisement

Table 2 Nucleotide sequence variations in HPV16 of E6, E7, L1 ORFs, lineage classification and predicted amino acid changes

From: Variants of human papillomaviruses 16 (HPV16) in Uigur women in Xinjiang, China

      E6    E7   L1  
HPV16Varians    G96A A131C T178G T295G T350G A647G 6901-6902 6951-6953 A6989G
Amino acid changes      D25E D64E L83V N29S 448insSer 464delAsp  
E Referene    G A T T T A insATC/GTC delGAT A
AA    G A T T G A ATC GAT A
As    G A G T T G ATC GAT A
Af    G A T T T A ATC GAT A
   Prevalence          
XJ-4 EP No.(%)        ATC GAT g
XJ-25 EP 8 (18.6)        ATC GAT  
XJ-28 EP         ATC GAT  
XJ-15 EP         ATC GAT  
XJ-17 EP         ATC GAT  
XJ-31 EP         ATC GAT  
XJ-33 EP         ATC GAT  
XJ-39 EP         ATC GAT  
XJ-1 E-350G 34 (79.1)      G   ATC GAT  
XJ-2 E-350G       G   ATC GAT  
XJ-3 E-350G       G   ATC GAT  
XJ-6 E-350G       G   ATC GAT  
XJ-7 E-350G       G   ATC GAT  
XJ-8 E-350G   a     G   ATC GAT  
XJ-9 E-350G       G   * * *
XJ-10 E-350G       G   ATC GAT  
XJ-11 E-350G       G   GTC GAT  
XJ-12 E-350G       G   ATC GAT  
XJ-14 E-350G       G   ATC GAT  
XJ-16 E-350G       G   ATC GAT  
XJ-18 E-350G       G   ATC GAT  
XJ-20 E-350G       G   ATC GAT  
XJ-21 E-350G       G   ATC GAT  
XJ-22 E-350G       G   ATC GAT  
XJ-24 E-350G       G   ATC GAT  
XJ-29 E-350G       G   ATC GAT  
XJ-31 E-350G       G   ATC GAT  
XJ-32 E-350G       G   ATC GAT  
XJ-34 E-350G       G   * * *
XJ-36 E-350G       G   ATC GAT  
XJ-37 E-350G       G   ATC GAT  
XJ-38 E-350G       G   ATC GAT  
XJ-40 E-350G       G   * * *
XJ-41 E-350G       G   ATC GAT  
XJ-42 E-350G       G   ATC GAT  
XJ-43 E-350G       G   ATC GAT  
XJ-13 E-350G      G G   ATC GAT  
XJ-19 E-350G      G G   ATC GAT  
XJ-23 E-350G      G G   ATC GAT  
XJ-27 E-350G      G G   ATC GAT  
XJ-30 E-350G      G G   ATC GAT  
XJ-35 E-350G      G G   ATC GAT  
XJ-5 AS 1 (2.3)   c G     ATC GAT  
  Mutation Prevalence (%) 2.3 2.3 2.3 14.0 79.1   100 100 2.4
  1. Capital letters indicate variants with an amino acid change, Lower-case letters indicate silent mutations; The asterisk (*) indicates which segment failure to amplification